All Articles

CanTex Capital's landmark sale of a 1.3M sq ft portfolio to Partners Group highlights booming demand for DFW's strategic shallow bay industrial assets.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

An expanded partnership aims to move businesses from AI experimentation to autonomous operations, tackling the critical 'last-mile problem' of value realization.

With a multi-billion dollar track record of IPOs and acquisitions, the veteran CEO's appointment signals Frazier's focus on navigating complex markets.

With new CEO Stan Lequin and private equity backing, Fidus Systems is pivoting to infuse AI into embedded design, signaling a new era of growth and M&A.

This April, families nationwide are walking to fund a new strategy for Lennox-Gastaut Syndrome, aiming to slash diagnosis times and find real cures.

Metazoa's new Intelligent Assistant for Salesforce goes beyond diagnostics, promising to actively help admins and developers remediate org complexity.

Energy Capital Partners is buying back nuclear services leader EnergySolutions, signaling Wall Street's growing confidence in nuclear's role in the energy future.

Amid financial headwinds, radiation therapy firm Accuray appoints a proven sales leader to spearhead a critical commercial transformation.

Hundreds of thousands of U.S.-born children live in exile after parental deportation. A new initiative aims to restore their rights and build a path home.

With its public debut on the horizon, S&P Global Mobility hires a seasoned expert in corporate separations to lead its financial structuring.

Apnimed has secured up to $150M to launch AD109, a potential first-ever pill for sleep apnea, promising relief for millions tired of CPAP machines.

At AAN 2026, SK Life Science will present new cenobamate data and survey findings that expose a critical communication gap in epilepsy care.

Digital health leader Bunny Ellerin joins Aegis Ventures as Chief Ecosystem Officer, a strategic move to fuel AI-native innovation through network power.

Two family-founded Glendora dental practices, now led by the next generation, partner with a national group to preserve their legacy and expand care.

A long-acting ketamine injection shows promise in treating severe depression without the harsh side effects and monitoring, potentially expanding access for millions.

The Permian energy solutions provider is raising $390 million to pay down existing debt and fund a major expansion of its distributed power business.

With a $5M private placement, Ubercrete is one step closer to a public listing and revolutionizing the construction industry with its advanced concrete tech.

Nearly half of Cornerstone Capital Bank's loan officers are top national producers. We unpack the powerful support system that fuels this industry-leading success.

With record revenue and A-list fans, British MedTech firm LYMA is doubling down on the US market, blending clinical data with celebrity appeal.